➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
AstraZeneca
Medtronic
McKinsey
McKesson

Last Updated: October 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Saccharin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Saccharin?

Saccharin is an investigational drug.

There have been 11 clinical trials for Saccharin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2013.

The most common disease conditions in clinical trials are Sinusitis, Hypertension, and Chronic Disease. The leading clinical trial sponsors are St. Paul's Hospital, Canada, National Cardiovascular Center Harapan Kita Hospital Indonesia, and Osypka Germany.

Recent Clinical Trials for Saccharin
TitleSponsorPhase
Betadine Effect on Nasal Mucosa CiliaBoston Medical CenterEarly Phase 1
Povidone-Iodine Rinses as an Adjuvant Therapy Post-OperativelySt. Paul's Hospital, CanadaN/A
Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort StudySt. Paul's Hospital, CanadaEarly Phase 1

See all Saccharin clinical trials

Clinical Trial Summary for Saccharin

Top disease conditions for Saccharin
Top clinical trial sponsors for Saccharin

See all Saccharin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
AstraZeneca
Medtronic
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.